Glycochemistry : sugar engineering and active ingredient delivery

Enhancing the efficacy, stability, and specificity of molecules through glycoscience​

Are you looking to solubilize a hydrophobic active ingredient, develop targeted therapies (AAV), design effective vaccines, or create bio-guided cosmetic ingredients?

To address these challenges, CAPACITÉS transforms the complexity of sugars into concrete R&D solutions for the pharmaceutical, cosmetics, and nutrition industries.

Summary

Services

No matter what challenges you face, our experts provide you with practical and innovative solutions.

Glycochemistry and molecular targeting​

Although your active ingredients show promise, they often lack specificity or cause adverse effects.

The attachment of targeted sugar moieties (site-selective glycoconjugation) transforms your molecules into “guided missiles” recognized by specific cellular receptors (lectins).

  • Increased therapeutic index and reduced toxicity.
  • Modification of the surface of viral capsids (AAV) and antibodies (ADC).
  • Development of glycoconjugate vaccines that elicit a strong immune response.

In a nutshell

Synthesis of Glycosides​

Bioconjugation

Development of glycoconjugates​

Measurement of glycomolecules ​

Synthesis of glycosides

Development of glycoconjugates

Quantification of glycomolecules

Solubility and stability of active ingredients​

In fact, many active ingredients remain difficult to utilize due to their insolubility in water or their instability.

Therefore, we use commercially available, chemically modified cyclodextrins to encapsulate and protect the target molecule.

  • A 10- to 100-fold increase in bioavailability and water solubility.
  • Prolonged, time-controlled release (slow-release).
  • Protection against oxidation and masking of odors and bitterness.

In a nutshell

Inclusion

Complexation

Solubility

Stability

Extended-release

Our expertise in sugar chemistry

  • Organic Synthesis: Custom synthesis of complex carbohydrate molecules, from proof of concept to pilot-scale production.
  • Bioconjugation and targeting: Covalent and site-specific grafting of glycan motifs onto proteins, peptides, antibodies, and nanoparticles.
  • Vectorization and Formulation: Design and modification of custom cyclodextrins for the microencapsulation of active ingredients (cyclodextrin encapsulation, improved bioavailability, active ingredient, solubilization of hydrophobic molecules).
  • Interactions and screening: Detailed analytical characterization, quantification of glycomolecules, and validation of inhibition on biological targets (measurement of sugar-protein affinity, lectin inhibition assay, glycan-receptor interactions, HPAEC-PAD quantification)

In a nutshell

Synthesis

Bioconjugation

Vectorization

screening

Engineering at CAPACITÉS

Nantes chemistry laboratory 

On the one hand, CEISAM focuses primarily on three research areas: the synthesis of organic molecules and hybrid materials, methodological developments in analytical chemistry, and molecular modeling.

Our technical ressources

We have access to more than 150 pieces of equipment in the University of Nantes’ laboratories. 

Need an innovative and resourceful partner?

Capacités teams inspire, harness and couple numerous cutting-edge skills covering a wide range of applications and expertise to meet all of your innovation needs with passion and commitment!

or send us a message:






    Required fields

    Centrifugal Partition Chromatography

    The double advantage of Centrifugal Partition Chromatography is that solvent consumption and purification process time are drastically reduced.

    We work to identify the appropriate solvent and the hydrodynamic characterization of each stationary phase in order to optimize purification methods at the industrial scale. We use digital models to help transfer the process to the industrial scale and to ensure that the projected calculations are valid.

    Our engineering and R&D services

    Our experts work with manufacturers of extracts, fragrances, biomolecules and active ingredients. Together, we optimize purification processes by developing and adjusting the processes and enriching and purifying molecules.

    Molecule Extraction and Purification

    Comparing extraction processes, purifying natural and synthetic substances, and developing methods for fractionating molecules of interest.

    Fractionation of biotechnologically produced metabolites

    Characterizing the extract before fractionation and selecting the appropriate separation method to obtain an optimal concentration of the purified substance.

    CPC column design, sizing, and characterization

    Optimizing separation at a given scale, scaling up, or determining optimal dimensions of a centrifugal partition chromatography column for industrial-scale purification.

    Purification process mastery and optimization

    Reducing the number of steps in the purification process for natural substances with high added value (peptides, alkaloids)

    Preparing CPC column scale changes

    Scaling a CPC purification process to the industrial scale and reducing the volume of solvent used by 75%.

    Challenges we’ve met

    Need an innovative and resourceful partner?

    Capacités teams inspire, harness and couple numerous cutting-edge skills covering a wide range of applications and expertise to meet all of your innovation needs with passion and commitment!

    or send us a message:






      Required fields

      Cyclodextrins for Microencapsulation

      Cyclodextrins have an inclusion capacity that enables many hydrophobic compositions to become soluble in an aqueous solution.

      There are many uses for this molecular tool, such as controlling the release of scents and flavors, improving the bioavailability of a therapeutic compound, capturing pesticides, encapsulating toxic organic compounds present in water, etc.

      Our engineering and R&D services

      Our experts work with you on your research and development projects. They help you develop formulation strategiesoptimize inclusion complexesimprove compound solubility, ensure stability in volatile molecules, and assist in many other research problems.

      Improving inclusion properties

      Optimizing the stability, solubility, and bioavailability of active and inactive ingredients in medicine

      Complexation studies

      Characterizing inclusion and complexation properties to make a composition’s hydrophobic molecules water soluble

      Determining cyclodextrin-ligand affinity constants

      Measuring the molecular binding affinity between a ligand and its target via Nuclear Magnetic Resonance (NMR)

      Aqueous solubility study by phase diagram

      Measuring the solubility of an active or hydrophobic ingredient before and after cyclodextrin complexation

      Encapsulated molecule stability study

      Using cyclodextrins to protect the content of an active substance over time and to prevent the appearance of degradation products

      Mastering sustained release: antagonist cyclodextrins

      Encapsulating and binding molecules to reduce active ingredients’ effects in a target environment

      Need an innovative and resourceful partner?

      Capacités teams inspire, harness and couple numerous cutting-edge skills covering a wide range of applications and expertise to meet all of your innovation needs with passion and commitment!

      or send us a message:






        Required fields

        Analytical chemistry : NMR, 2D NMR, IRMS

        Our experts in analytical chemistry provide your projects with exceptional technical resources and know-how.

        Our Capacités experts in analytical chemistry have developed an exceptional know-how in Nuclear Magnetic Resonance (1D NMR and 2D NMR) and in Isotope Ratio Mass Spectrometry (IRMS).
        Access to a large pool of equipment allows us to support industrial projects, from sample preparation to characterization.

        We are specialized in very high precision quantification projects and in the analysis of complex matrices. We help our clients to innovate in the study of metabolism, the fight against counterfeiting, the determination of the purity of active molecules, or the monitoring of chemical transformations.

        Summary

        Services

        Strategy and consulting

        Diagnosis and selection

        Process development

        Quality control

        Development of methods

        Metabolomic and lipidomic analyses

        Validate a therapeutic target or refine the description of a pathology through the identification and qualification of biomarkers responsible for changes between two states.

        Our experts master different types of analyses of biological samples. They perform targeted and non-targeted profiling and highlight changes between states of the biological matrices studied.

        In a nutshell

        Targeted analysis

        Metabolomic profiling

        Metabolic Footprint

        Analysis of matrices

        Data processing

        Targeted analysis

        Metabolomic profiling

        Metabolic Footprint

        Analysis of matrices

        Data processing

        Quantitative NMR (nuclear magnetic resonance)

        Our expertise is to qualify reference substances, determine the purity of molecules and certify their compliance with international quality standards.

        Our experts assist pharmaceutical and cosmetic companies in certifying the purity of their reference molecules using NMR methods.

        In a nutshell

        NMR acquisition parameters

        NMR processing parameters

        Method validation and parameter verification

        Product origin authentification

        Optimization of the NMR tool

        NMR acquisition parameters

        NMR processing parameters

        Method validation and parameter verification

        Product origin authentification

        Optimization of the NMR tool

        Publication

        Didier G. Diomande, Estelle Martineau, Alexis Gilbert, Pierrick Nun, Ariaki Murata, Keita Yamada, Naoharu Watanabe, Illa Tea, Richard J. Robins, Naohiro Yoshida, and Gérald S. Remaud Position-Specific Isotope Analysis of Xanthines: A 13C Nuclear Magnetic Resonance Method to Determine the 13C Intramolecular Composition at Natural Abundance.v

        Analytical Chemistry 2015 87 (13), 6600-6606. DOI: 10.1021/acs.analchem.5b00559

        Quantitative 2D NMR (2D nuclear magnetic resonance)

        Development of fast and quantitative 2D NMR acquisition methods.

        Our experts have developed a protocol for the implementation of targeted and non-targeted metabolic and lipidomic studies.

        In a nutshell

        Rapid quantification for metabolomics and lipidomics

        Quantification of polysaccharides by 2D NMR

        Rapid quantification for metabolomics and lipidomics

        Quantification of polysaccharides by 2D NMR

        Publication

        Estelle Martineau, Serge Akoka, Renaud Boisseau, Benoît Delanoue, and Patrick Giraudeau. Fast Quantitative 1H–13C Two-Dimensional NMR with Very High PrecisionAnalytical Chemistry 2013 85 (9), 4777-4783

        Estelle Martineau, Kamel El Khantache, Marion Pupier, Patricia Sepulcri, Serge Akoka, Patrick Giraudeau, Non-linear effects in quantitative 2D NMR of polysaccharides: Pitfalls and how to avoid them, Journal of Pharmaceutical and Biomedical Analysis, Volume 108, 2015, Pages 78-85, ISSN 0731-7085

        Estelle Martineau, Jean-Nicolas Dumez, Patrick Giraudeau. Fast quantitative 2D NMR for metabolomics and lipidomics: A tutorial Magnetic Resonance in Chemistry. 04 June 2019

        IRMS (Isotope Ratio Mass Spectrometry)

        To analyze the 13C, 15N, 2H, 18O and 34S isotopes present in organic matter, for a better understanding of metabolism in the fields of health and nutrition.

        The mastery of compound-specific analysis allows to obtain 13C and/or 15N profiles of different matrices.

        In a nutshell

        Average isotopic composition by EA-IRMS

        GC-IRMS analyse

        Average isotopic composition by EA-IRMS

        GC-IRMS analyse

        Publication

        Tea, I., Martineau, E., Antheaume, I. et al. 13C and 15N natural isotope abundance reflects breast cancer cell metabolism. Sci Rep 6, 34251 (2016). https://doi.org/10.1038/srep34251

        Olivier L Mantha, Caroline Goupille, Jean-François Dumas, Richard Robins, Philippe Bougnoux, Régis Hankard, Arnaud De Luca, Natural isotopic abundances as markers of compliance in clinical trialsThe American Journal of Clinical Nutrition, Volume 111, Issue 5, May 2020, Pages 1109–1110

        Tea I, Le Guennec A, Frasquet-Darrieux M, Julien M, Romek K, Antheaume I, Hankard R, Robins RJ. Simultaneous determination of natural-abundance δ15N values and quantities of individual amino acids in proteins from milk of lactating women and from infant hair using gas chromatography/isotope ratio mass spectrometry. Rapid Commun Mass Spectrom. 2013 Jun 30;27(12):1345-53.

        Engineering at CAPACITÉS

        Our Analytical Chemistry experts perform their engineering duties in the very research laboratories of Nantes Université themselves, most notably at CEISAM. They strive to combine technical resources and scientific discovery to meet your R&D needs.

        Challenges we’ve met

        Need an innovative and resourceful partner?

        Capacités teams inspire, harness and couple numerous cutting-edge skills covering a wide range of applications and expertise to meet all of your innovation needs with passion and commitment!

        or send us a message:






          Required fields

          A unique translational expertise in gene therapy

          Our experts in viral vector production work in the gene therapy laboratory in Nantes to support you in the development of new drugs.

          CAPACITÉS’ teams in monitoring host immune response, preclinical assays and viral vector production offer a complete range of support for the development of drug candidates.

          With internationally recognized know-how in the field of gene therapy, our experts offer the responsiveness of a CRO (Contract Research Organization) in the discovery and development phases of gene therapy products.

          Summary

          Services

          Proof of concept

          Preclinical data

          Manufacturing

          Preclinical assays

          Technology platforms

          Viral vectors manufacturing

          In close collaboration with TaRGeT UMR 1089 gene therapy laboratory (UMR INSERM-Nantes Université), we propose the development of processes for the production and characterization of viral gene transfer vectors derived from adenoviruses and AAV. These vectors are intended for applications ranging from basic research to preclinical trials.

          In a nutshell

          AAV vectors

          vector plasmids

          analysis processes

          R&D

          Production of recombinant AAV vectors

          Custom construction of vector plasmids

          Development of analysis processes and techniques

          R&D

          Vector production center – CPV

          The research teams and the vector production center of TaRGeT UMR 1089 Gene therapy laboratory work together to ensure reliable, high-quality production and characterization of viral vectors. They can also develop custom analytical tests and new innovative characterization tests.

          In a nutshell

          Upstream technologies

          Downstream technologies

          Upstream technologies

          Downstream technologies

          Immune monitoring analyses

          Experts in the monitoring of host immunity in gene therapy protocols, we provide analyses for monitoring immune responses directed against the vector and against the transgene product. We assist in the development of your gene therapy products, from the research project to toxicology studies and clinical trials.

          In a nutshell

          Humoral immunity

          Cellular immunity

          Sample preparation

          Humoral immunity

          Cellular immunity

          Sample preparation

          Tests available for :

          Gene Therapy Immunology Core – GTI

          Analyses for monitoring the immune response against the vector or the transgene product are carried out by the GTI (Gene Therapy Immunology Core) platform of TaRGeT UMR 1089 Gene therapy laboratory. This platform has complete technical means for the Immune monitoring  of gene therapy studies.

          In a nutshell

          ELISpot

          Cell proliferation test

          Tetramer

          flow cytometry

          Cellular neutralization test

          ELISA

          Western Blot

          Luminex

          Plate washer

          Multimode microplate reader

          ELISpot reader

          Turbo gel transfer system

          Preclinical analysis

          Evaluation of the biodistribution and expression profile of transgenes is necessary to understand the pharmacology and pharmacokinetics of a therapeutic product. We are recognized as experts in the molecular and biochemical analyses required to assess the efficacy and biosafety of gene therapy products.

          In a nutshell

          Evaluation of functionality

          Evaluation of biodistribution

          Expression Profile Assessment

          development of preclinical studies

          Absolute quantification

          Preclinical analysis core – PAC

          Our leading expertise, in the evaluation of biodistribution and expression profiles of transgenes, is implemented using multiple tools and equipment available on PAC (Preclinical Analytics Core) platform of the Nantes UMR1089 gene therapy laboratory.

          In a nutshell

          Tissue shredder

          Pipetting machine

          Nanophotometer

          microplate reader

          Colorimetric and fluorimetric reader

          Electrochemiluminescence reader

          PCR and qPCR instruments

          Turbo gel transfer system

          Engineering at CAPACITÉS

          Our gene therapy experts carry out their engineering work directly in the research laboratories of Nantes Université, particularly in TaRGeT UMR 1089 Gene therapy laboratory
          On a daily basis, they combine technical resources and scientific discoveries to meet your R&D challenges.

          Need an innovative and resourceful partner?

          Capacités teams inspire, harness and couple numerous cutting-edge skills covering a wide range of applications and expertise to meet all of your innovation needs with passion and commitment!

          or send us a message:






            Required fields

            Robotic Innovation and Automation

            Our teams create and design innovative, tailor-made robotics solutions for all lines of business.

            Using robotics increases autonomy and performance, and it provides sustainable innovation in a wide range of fields: industry, agriculture, construction, civil engineering, etc
            We engineer state-of-the-art robotics solutions by combining top robotics research, technological innovation in artificial intelligence and our experience with unique projects.

            Our expertise ranges from industrially automating difficult tasks to using innovative technology in autonomous robots, with careful consideration for the human-machine relationship. Rising to new challenges drives us. Our goal is to boost your competitive edge by advancing your R&D.

            Summary

            Services

            Formalising the need

            Pre-project studies

            Development of a prototype

            Industrialisation of the solution

            On-site visits

            Robotics and Automation Strategies

            We are your partner for automating your machines and incorporating robotics into your operations. Our teams brainstorm ideas with you, conduct on-site visits and carry out the pre-project studies needed to secure your investments. For each innovative project, our experts develop a robotic system adapted to your business.

            Autonomous Robotics in Uncertain Environments

            Our mobile robotics engineers have a broad range of experience with different lines of work and fields of application (service robotics): agricultural robotics, under-sea construction, underground construction, defense, etc. They put their expertise to use to design autonomous and intelligent robots that are adapted to complex environments.

            Automating Industrial Processes

            Our teams are highly skilled in industrial robotics, process analysis and manual operations. We design specialized solutions for all lines of work by combining innovative robotics technology with standard industrial equipment. We develop and/or optimize manufacturing processes to increase productivity, enhance performance and improve working conditions.

            Data Science and Artificial Intelligence for Industry

            We work closely with the LS2N laboratory and utilize the latest research in AI-data science for your projects, from implementing one autonomous robot to digitizing and automating your workshops (industry 4.0). By using your data, we can improve your processes, anticipate your maintenance operations or even monitor the state of your machines.

            Challenges we’ve met

            Need an innovative and resourceful partner?

            Capacités teams inspire, harness and couple numerous cutting-edge skills covering a wide range of applications and expertise to meet all of your innovation needs with passion and commitment!

            or send us a message:






              Required fields

              Industrial valorisation of microalgae

              We offer a complete range of services geared towards the industrial use of microalgae, from strain screening to production scale-up.

              Our teams are there to guide you when it comes to selecting strains and determining the optimal conditions for microalgal cultivation. We launch a battery of tests on various production systems, be they closed or open, and are able to test or develop different types of custom-made photobioreactors.
              We also manage recovery operations up to the extraction-purification of the relevant microalgal compounds: carbohydrates, lipids and proteins.

              Our efforts go a long way towards furthering the development of high-potential innovative products such as bioplastics, biofuels, biomaterials, bio-bitumen, spirulina, etc.
              By means of R&D services and collaborative research projects, Capacités presents manufacturers and laboratories with their GEPEA Laboratory know-how in the industrial use of microalgae: reusing CO2, nitrogen and waste heat from industrial activities that cause pollution in order to create valuable resources.

              Summary

              Services

              Strategy and consulting

              Diagnostics and screening

              Process development

              Biorefining

              Biorefining

              No matter the challenge, our experts deliver practical and innovative solutions

              Microalgae, a revolution for

              Natural compounds

              Microalgae are an innovative source of natural compounds: EPA/DHA, pigments, peptides, proteins, polysaccharides and sterols.

              Nutraceutics | Cosmetics

              Active molecules

              Microalgae are an innovative source of active molecules with unique properties — perfect for enriching your pipeline.

              Biotechnologies | Pharmaceuticals

              Biomaterials

              Microalgae enable the development of innovative materials to replace petroleum-based components.

              Chemical industries | Plastics manufacturers

              Reducing CO₂ emissions

              Microalgae cultivation makes it possible to integrate Carbon Capture, Usage and Storage (CCUS) technologies into plants.

              Heavy industries

              Screening, selection and optimisation of strains

              Our teams have access to the collections of strains from the GEPEA and MMS research laboratories. Where necessary, they can also make use of the RCC and NCC collections, among others. Due to our expertise in strain characterisation, we are able to guide you through the screening, isolation and purification stages.

              In a nutshell

              STRAIN PORTFOLIO

              SCREENING

              ISOLATION

              CHARACTERISATION

              PURIFICATION

              TORUS PHOTOBIOREACTORS

              Development, testing and automation of cultivation processes

              On the strength of our technical resources, we are able to test, measure and monitor all the relevant cultivation parameters for algal biomass production in real time: carbon, nitrogen and phosphorus levels, quantity of light, quantity of water, biological contamination, weather conditions, etc.

              We also work on automating cultivation processes by designing monitoring tools capable of automatically adjusting the cultivation parameters in photobioreactors.

              In a nutshell

              TECHNOLOGY TESTING

              CONCENTRATION AND HARVESTING

              PROCESS DEVELOPMENT

              GROWTH MONITORING

              WASTEWATER TREATMENT

              Cultivation

              Biomass concentration and harvesting

              Process development

              Growth monitoring

              Treatment and industrial waste recovery

              Biorefining, comparative testing and combining unit operations

              Our specialists examine the integration of unit operations, either in the research laboratory or on site, with a view to completely recovering the biomass produced. We develop the process up to the extraction-purification of those biomolecules indicated in your specifications. Our research is validated in real-world conditions and on a representative scale.

              In a nutshell

              HARVESTING

              MILLING – ENRICHMENT

              EXTRACTION

              PURIFICATION

              CONDITIONING

              Harvesting

              Grinding

              Concentration and enrichment of target metabolites

              Extraction

              Adsorption

              Biomass conditioning methods

              Mass balance, biomass analysis

              Along with the unwavering support of the GEPEA and CEISAM laboratories, we possess the expertise and range of analytical equipment necessary for a precise biochemical characterisation of the organic matter present, the metabolites produced and the biomolecules extracted. We are thus able to carry out our analyses in an entirely autonomous and confidential manner.

              In a nutshell

              PROTEIN DOSAGE

              COMPOUND PROFILING

              CLASS PROFILING

              FAMILY PROFILING

              SPECTRO ANALYSIS

              NMR

              Dosage

              Profiling

              Types of analysis

              Scaling up the microalgae cultivation processes

              We test and validate the scale-up and industrialisation conditions of the processes. Our wide array of equipment allows us to design pilots and to implement laboratory-scale production, as well as to make and deliver samples destined for trials (consumer, preclinical and clinical).

              In a nutshell

              IDENTIFYING CONSTRAINTS

              PILOT PLANT

              INDUSTRIALISATION

              CUSTOM MANUFACTURING

              Identifying and validating constraints

              Industrialisation of the process

              Custom manufacturing

              Collaborative research activities and R&D projects

              Since we have access to the technical resources and researchers belonging to the GEPEA Laboratory, we are able to develop innovative projects through R&D in the marine bioresources recovery fields, and particularly in microalgae.

              In a nutshell

              INDUSTRIAL ECOLOGY

              WASTEWATER TREATMENT

              BIOFUELS

              BATCH PRODUCTION

              INNOVATIVE PROCESSES

              EQUIPMENT TESTING

              ALGOSOLIS technology and R&D facility

              AlgoSolis provides us with the necessary equipment and infrastructure for the controlled, intensive and sustainable use of microalgal resources on a large scale. This platform allows the various stakeholders to develop microalgal cultures in open and closed ponds. The modelling and designing of custom-made photobioreactors is also available. This technology service promotes the development of innovative research projects in the field of blue biotechnology.

              In a nutshell

              PRE-CULTURE ROOMS

              INTENSIFIED PHOTOBIOREACTORS

              AIRLIFT PHOTOBIOREACTORS

              CLOSED RACEWAYS

              OUTDOOR PRODUCTION

              GREENHOUSE PRODUCTION

              BIOREFINERY HALL

              Identifying and validating constraints

              Industrialisation of the process

              Custom manufacturing

              Training in microalgae cultivation

              This professional training course, which is headed up by the research professors of the GEPEA Laboratory and the engineers at Capacités, provides the theoretical and practical elements involved in the entire microalgae production chain, from the preparation of media and inoculums to the ultimate harvesting of the biomass produced in natural light. The course is endorsed by the Pôle Mer Bretagne Atlantique.

              • Good cultivation practices [1 day]
              • Cultivation engineering [2 days]
              • Harvesting microalgae [1 day]

              Engineering at Capacités

              Our biodegradability experts carry out their engineering work directly in the research laboratories of Nantes Université, in particular at the GEPEA. On a daily basis, they combine technical means and scientific discoveries to meet your R&D challenges.

              Challenges we’ve met

              Need an innovative and resourceful partner?

              Capacités teams inspire, harness and couple numerous cutting-edge skills covering a wide range of applications and expertise to meet all of your innovation needs with passion and commitment!

              or send us a message:






                Required fields

                Preclinical trials for drug development and drug candidate validation

                Our experts lead preclinical testing and support pharmaceutical and biotechnology companies in the drug discovery and drug development phases: pharmacology, pharmacokinetics and toxicology studies.

                Save time in the experimentation phase. We develop the preclinical studies for the validation of drug candidates and food compounds, evaluate the therapeutic or protective effects of molecules of interest and characterize the functional effects of a pharmaceutical product (action, target organ, active dose).

                Associated with the facility core for function exploration Therassay (certified ISO9001: 2015), we operate as a CRO (contract research organization). WE offer a simplified service covering a wide range of functions: neuromuscular, metabolic, vascular, cardiac, pulmonary, digestive, oncology-haematology; as well as consulting services, study design and preclinical trials.

                Summary

                Services

                Benchmarck and consulting

                Study design

                Preclinical assays

                Assessments: Analyses, Recommendations

                Support: development, certification…

                Preclinical research and assays on muscle function

                Physiopathological analyses, muscle fatigue studies and muscle tone measurements are conducted by our experts to study muscle pathologies such as sarcopenia and muscle atrophy.

                Different methods and a high level of expertise are offered to answer specific questions related to the evaluation of muscular strength, the analysis of gain or loss of muscular strength and the improvement of cognitive functions or stress and anxiety states.

                In a nutshell

                evaluation of muscular strength

                analysis of gain or loss of muscular strength

                improvement of cognitive functions

                stress and anxiety states

                Assessment of general behavior and analysis of global motor and muscle function

                Effectiveness laboratory testing of pharmaceutical products and food supplements on neuromuscular function: strength, muscle fatigue, endurance

                Measurement of muscle contractions at the organ, muscle cells and calcium homeostasis levels

                Evaluate the efficacy of food supplements or drug candidates: compare a reference product with products on the market (plant extracts, soluble milk proteins, muscle relaxants, etc.)

                Pharmacological approach: drug trials, plant extracts, etc.

                 

                Neuromuscular evaluation: anxiety, depression

                Preclinical trials for the functional exploration of the muscular system associated with cognitive functions.

                Preclinical evaluation and validation of drug candidates in onco-hematology

                This unique expertise is offered to biotechs, pharmaceutical companies and research institutions to evaluate the clinical potential of drug candidates for hematological malignancies : lymphomas, myelodysplastic syndromes, hematological malignancies, etc.

                In a nutshell

                In vitro study

                cell lines

                clinical potential of drug candidates

                hematological malignancies

                Engineering at Capacités

                Therassay is a core facility functional exploration for cardiovascular, metabolic, neuromuscular, digestive, respiratory and cancerous pathologies

                Challenges we’ve met

                Need an innovative and resourceful partner?

                Capacités teams inspire, harness and couple numerous cutting-edge skills covering a wide range of applications and expertise to meet all of your innovation needs with passion and commitment!

                or send us a message:






                  Required fields

                  Capsulæ is a leading company in the field of microencapsulation. It develops solutions for industrial customers to optimize active and inactive ingredients’ performance and facilitate their use. The company had a project that required finding an effective alternative solution to meet its client’s biodegradability requirements. It turned to the experts from CAPACITÉS to develop a new formula involving its method of encapsulation by cyclodextrins. The preliminary results are promising.

                  Augmenter la biodisponibilité d’un principe actif hydrophobe grâce à l’encapsulation par cyclodextrine

                  Increasing the bioavailability of a hydrophobic active ingredient

                  In the fields of food and feed, microencapsulation can improve an active ingredient’s stability. “Nevertheless, using conventional encapsulation materials does not always let us obtain all the beneficial effects from some active ingredients. This is due to weak bioavailability and is often linked to hydrophobicity,” explains Gisèle Ongmayeb, PhD, the R&I manager at Capsulæ.

                  Capsulæ wanted to explore other materials with structures that can protect hydrophobic active ingredients and simultaneously facilitate their bioavailability. Cyclodextrins were identified among these materials. They originate naturally and meet current regulatory demands concerning material biodegradability.

                  In this context, the company asked CAPACITÉS’ experts to encapsulate vitamin E as a model molecule. The intermediary results are very encouraging; the cyclodextrins selected allowed vitamin E to be encapsulated and improved its solubility in an aqueous phase. The results delivered in August 2021 confirm this trend, and a second phase of the project will begin with the aim of optimizing the process to reduce costs. Capsulæ’s goal is to offer its clients an innovative encapsulation technique at a competitive price.

                  An efficient collaboration in Research & Innovation for industry

                  “Private companies must join forces with researchers in academic laboratories, such as the experts at CAPACITÉS, to overcome certain scientific obstacles and use the latest methods of characterization. So, you must collaborate to innovate,” recommends Gisèle Ongmayeb.

                  In the context of this collaboration, “CAPACITÉS has knowledge and a high level of scientific expertise in a particular groundbreaking skill. Capsulæ has extensive experience and a unique global vision of the encapsulation market. For CAPACITÉS, this is the opportunity to make full use of its expertise with cyclodextrins for new industrial applications,” adds Gisèle Ongmayeb.

                  Do you need help solving bioavailability issues for an active compound? CAPACITÉS is your partner for finding ingenious solutions. Contact us.

                  Due to the lack of standardised tests, the cosmetics industry is unable to evaluate the biodegradability of a mixture of substances with any degree of precision. Expectations of a simple and reliable method are high: manufacturers wishing to optimise the environmental impact assessment of their products, and European institutions looking to reassure and protect their citizens. In order to confront this methodological void head on, experts from CAPACIÉS and the GEPEA Laboratory, backed by Tronico and L’Oréal, teamed up to develop a new method for assessing the biodegradability of complex matrices. The issue lies in its standardisation, so as to meet the manufacturers’ economic requirements in terms of speed and reliability. New measuring equipment that is designed to automate testing is already being evaluated. ECHA, the European Chemicals Agency, is keeping a close eye on the progress of this innovative approach.

                  We asked two of CAPACITÉS experts to explain this concept in more depth: Prof. Gérald Thouand, a researcher at the GEPEA Laboratory, and Mickaël Crégut, an R&D engineer specialising in biodegradability and ecotoxicity.

                  Discussions are under way in Europe about providing a framework for the assessment of the biodegradability of mixtures. Could you tell us a bit more about this issue?

                  G. Thouand: The European legislation, REACH, has been regulating pure substances since 2008. Eventually, mixtures will also be subject to legislation. We are all perfectly aware of the fact that it isn’t pure substances which are found in nature, but mixtures. A molecule can be perfectly biodegradable in a laboratory, yet not be biodegraded during wastewater treatment plant processing because it’s surrounded by hundreds of other molecules. This is what I call the “cocktail effect”, as no one has a standardised way to evaluate it.

                  For the time being, ECHA, the European Chemicals Agency, recommends isolating molecules in order to measure the biodegradability of each one separately. This is neither chemically nor technically feasible. Biodegradability and ecotoxicity specialists are simply unable to separate hundreds of substances from a mixture in a timely and cost-effective manner.

                  Manufactures are waiting for laboratories to offer them an alternative approach, so that they can finally be a driving force behind ECHA. The latter seeks to find a compromise between manufacturers’ capabilities with respect to evaluating their products, and a degree of certainty that the assessment methods employed are sufficiently reliable to protect society.

                  Do you have an answer for the manufacturers?

                  G. Thouand: Yes, Capacités and the GEPEA Laboratory, backed by L’Oréal and Tronico, have been developing a new approach for assessing the biodegradability and ecotoxicity of complex matrices since 2015.

                  We know that undegraded elements may remain after a biodegradation event and that these residues can be composed of hundreds of substances. We measure numerous parameters, including the toxicity of the final mixture, so as to assess whether it is more or less toxic than the initial mixture. Providing that there is no increase in toxicity, the mixture is characterised as biodegradable. This is what we refer to as “weight of evidence”.

                  In order to arrive at this conclusion, the complex matrix to be assessed and a certain quantity of environmental microorganisms are placed in a reactor. The substance is biodegraded if the microorganisms feed on it in order to grow: they consume oxygen to oxidise the substance and release CO2 to integrate it into their metabolism.

                  M. Crégut: In order to evaluate the biodegradability of a substance, there are thus four factors to be observed: oxygen decreases, carbon dioxide is produced, biomass is created and the substance disappears. These parameters are relatively easy to study separately, but very difficult to measure together. We managed to combine them into a single assessment system.

                  Repeating this procedure for four of five substances is already a painstaking task. Doing it for hundreds of substances would require an infinite amount of time… In order to address this issue, we developed a machine that carries out biodegradability and ecotoxicity testing automatically. Operators only have a single procedure to perform in the beginning, then they can leave it to carry on with the task for around 28 days.

                  Your testing method has been integrated into a new automatic assessment machine for establishing the biodegradability of mixtures. Can you tell us a bit more about its industrial roll-out?

                  M. Crégut: This is an important innovation, made possible by Tronico that backed the GEPEA Laboratory and Capacités from the very beginning, as well as L’Oréal that followed us. We received the first prototype in December 2020. At the moment, it’s in the laboratory evaluation phase. It will soon be sent to Eurofins in Nancy, where testing will be carried out under the aegis of L’Oréal that is financing the operation. Such field experiments are essential prior to the market launch in 2022.

                  G. Thouand: The main challenge was to combine all the parameters for assessing the biodegradability of a complex matrix into one machine, and in a way that was automatic and fast… We succeeded by combining numerous technologies that had already been mastered. We miniaturised each operation in order to create a compact machine that occupies only 1 m2. It takes only one person to operate it.

                  ECHA is looking for a compromise between their need for safety and the manufacturers’ need for a method that can be applied at a reasonable cost and within a reasonable time. Could your method be that compromise?

                  M. Crégut: Yes, that’s a possibility. In any case, ours will most likely be one of the methods recommended by ECHA for biodegradability testing. Together with L’Oréal, we published an article in the journal Green chemistry that was presented at SETAC Europe, the global biodegradability and ecotoxicity congress, in 2019. We feel that our approach is starting to become the general consensus.

                  It is a valid means of assessment that is economically viable, while addressing the key ecological issues. Our citizens need transparency, that’s normal. Manufacturers also need to understand precisely what this entails.

                  To find out more about our expertise in biodegradability and ecotoxicity, please visit our dedicated page or contact us directly.

                  An automated bioreactor to facilitate biodegradability assessment

                  In a nutshell

                  Key words

                  BiodegradabilityECOTOXICOLOGY

                  Discussions are under way in Europe about providing a framework for the assessment of the biodegradability of mixtures. Could you tell us a bit more about this issue?

                  G. Thouand: The European legislation, REACH, has been regulating pure substances since 2008. Eventually, mixtures will also be subject to legislation. We are all perfectly aware of the fact that it isn’t pure substances which are found in nature, but mixtures. A molecule can be perfectly biodegradable in a laboratory, yet not be biodegraded during wastewater treatment plant processing because it’s surrounded by hundreds of other molecules. This is what I call the “cocktail effect”, as no one has a standardised way to evaluate it.

                  For the time being, ECHA, the European Chemicals Agency, recommends isolating molecules in order to measure the biodegradability of each one separately. This is neither chemically nor technically feasible. Biodegradability and ecotoxicity specialists are simply unable to separate hundreds of substances from a mixture in a timely and cost-effective manner.

                  Manufactures are waiting for laboratories to offer them an alternative approach, so that they can finally be a driving force behind ECHA. The latter seeks to find a compromise between manufacturers’ capabilities with respect to evaluating their products, and a degree of certainty that the assessment methods employed are sufficiently reliable to protect society.

                  Do you have an answer for the manufacturers?

                  G. Thouand: Yes, Capacités and the GEPEA Laboratory, backed by L’Oréal and Tronico, have been developing a new approach for assessing the biodegradability and ecotoxicity of complex matrices since 2015.

                  We know that undegraded elements may remain after a biodegradation event and that these residues can be composed of hundreds of substances. We measure numerous parameters, including the toxicity of the final mixture, so as to assess whether it is more or less toxic than the initial mixture. Providing that there is no increase in toxicity, the mixture is characterised as biodegradable. This is what we refer to as “weight of evidence”.

                  In order to arrive at this conclusion, the complex matrix to be assessed and a certain quantity of environmental microorganisms are placed in a reactor. The substance is biodegraded if the microorganisms feed on it in order to grow: they consume oxygen to oxidise the substance and release CO2 to integrate it into their metabolism.

                  M. Crégut: In order to evaluate the biodegradability of a substance, there are thus four factors to be observed: oxygen decreases, carbon dioxide is produced, biomass is created and the substance disappears. These parameters are relatively easy to study separately, but very difficult to measure together. We managed to combine them into a single assessment system.

                  Repeating this procedure for four of five substances is already a painstaking task. Doing it for hundreds of substances would require an infinite amount of time… In order to address this issue, we developed a machine that carries out biodegradability and ecotoxicity testing automatically. Operators only have a single procedure to perform in the beginning, then they can leave it to carry on with the task for around 28 days.

                  Your testing method has been integrated into a new automatic assessment machine for establishing the biodegradability of mixtures. Can you tell us a bit more about its industrial roll-out?

                  M. Crégut: This is an important innovation, made possible by Tronico that backed the GEPEA Laboratory and Capacités from the very beginning, as well as L’Oréal that followed us. We received the first prototype in December 2020. At the moment, it’s in the laboratory evaluation phase. It will soon be sent to Eurofins in Nancy, where testing will be carried out under the aegis of L’Oréal that is financing the operation. Such field experiments are essential prior to the market launch in 2022.

                  G. Thouand: The main challenge was to combine all the parameters for assessing the biodegradability of a complex matrix into one machine, and in a way that was automatic and fast… We succeeded by combining numerous technologies that had already been mastered. We miniaturised each operation in order to create a compact machine that occupies only 1 m2. It takes only one person to operate it.

                  ECHA is looking for a compromise between their need for safety and the manufacturers’ need for a method that can be applied at a reasonable cost and within a reasonable time. Could your method be that compromise?

                  M. Crégut: Yes, that’s a possibility. In any case, ours will most likely be one of the methods recommended by ECHA for biodegradability testing. Together with L’Oréal, we published an article in the journal Green chemistry that was presented at SETAC Europe, the global biodegradability and ecotoxicity congress, in 2019. We feel that our approach is starting to become the general consensus.

                  It is a valid means of assessment that is economically viable, while addressing the key ecological issues. Our citizens need transparency, that’s normal. Manufacturers also need to understand precisely what this entails.

                  To find out more about our expertise in biodegradability and ecotoxicity, please visit our dedicated page or contact us directly.

                  Our projects

                  Characterizing ecotoxicity in complex substances

                  The client concerned is a leading player in the specialty ingredients sector for health and beauty. In 2019, it reaffirmed its confidence in Capacités and the GEPEA laboratory by requesting that their teams assess a new polymer’s ecotoxicity.

                  Discover